(London) Pfizer & BioNTech Infringed On Modernas’ Patent With COVID-19 Vaccine
By Zachary Stieber | The Epoch Times
Pfizer and BioNTech’s COVID-19 vaccine infringed on a patent held by rival Moderna, the High Court in London, England, found in a decision released on July 2.
The Pfizer-BioNTech and Moderna COVID-19 vaccines both utilize messenger ribonucleic acid (mRNA) technology.
Moderna patented mRNA processes that replace the nucleoside uridine with N1-methylpseudouridine, a modified RNA. The patent is titled, “ribonucleic acids containing n1-methyl-pseudouracils and uses thereof.”
The patent “is valid,” the court stated, adding that it was infringed “given that Pfizer/BioNTech conceded that it would be infringed if valid.”
The court rejected arguments made by Pfizer and BioNTech, including the argument that Moderna’s patent was not novel. It said parts of the patent were novel, from a method developed by the University of Pennsylvania.
The District Court of the Hague in 2023 found the patent to be invalid due to lack of novelty versus the method, but the London court said it weighed other evidence and found some factors persuasive that the Hague did not.
Frank Augstein/Reuters
Moderna in 2020 said it would not enforce patents related to COVID-19 against rival manufacturers. However, in 2022, it revoked the declaration, meaning Pfizer and BioNTech came into violation of the patent, the high court said in a related decision.
Justice Jonathan Richards wrote in the ruling, that “Even if the pledge was an express waiver of rights, it was validly retracted by the March 2022 statement since Pfizer/BioNTech had not by that date materially changed its position in reliance on the pledge.”
The court also ruled that a second patent held by Moderna was invalid.
Possible Appeals
All three companies said they disagreed with the parts of the court’s decision on which they lost, and it is expected that all parties will seek permission to appeal.
Pfizer and BioNTech said in a statement:
“These proceedings have no bearing on the safety and efficacy profile of our vaccine, as established by regulators worldwide.
“Irrespective of the outcome of this legal matter, we will continue to manufacture and supply the Pfizer-BioNTech COVID-19 vaccine in line with our agreements and established supply schedules.”
A spokesperson for Moderna said the company was pleased the court “recognized the innovation of Moderna scientists by confirming the validity and infringement” of one of its patents.
Pfizer, BioNTech, and Moderna are also involved in parallel proceedings in Germany, the Netherlands, Belgium, and the United States, much of which has been put on hold, as well as at the European Patent Office.
The London ruling comes at a time of financial strain for Moderna, whose shares have plummeted by more than 70 percent since the peak of the pandemic as demand and sales for Spikevax have fallen. Shares of Pfizer, meanwhile, are down about 29 percent since mid-2021.
*********
(TLB) published this article by Zachary Stieber | The Epoch Times
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
Header featured image (edited) credit: A nurse prepares to administer the Pfizer-BioNTech COVID-19 vaccine (Frank Augstein/Reuters)
Emphasis added by (TLB)
••••
••••
Stay tuned tuned…
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Leave a Reply